The global cryonics technology market is anticipated to grow significantly at a CAGR of 10.1% during the forecast period. Egg preservation/freezing, also known as mature oocyte cryopreservation, is a method used to save women's ability to get pregnant in the future. These preserved eggs can be combined with sperm in a lab and implanted in a female’s uterus for pregnancy. The factors such as increasing infertility, late pregnancy, and late marriage are propelling demand for egg preservation/ freezing, which in turn is further increasing the growth of the cryonics market across the globe. Infertility is a disease of the male or female reproductive system failure to achieve a pregnancy after 12 months or more.
Carrying pregnancy at an advanced age has complications, thus this technology can aid in the situation it is an easily approachable and affordable process With the development and advancement in oocyte freezing techniques. According to WHO's latest data, around 48 million couples, and 186 million individuals have infertility globally, and a further 15% of married couples across the globe are affected by infertility. Environmental and lifestyle aspects such as smoking, excessive alcohol consumption, obesity, and exposure to environmental impurities have been associated with lower fertility rates.
Browse the full report description “Global Cryonics Technology Market Size, Share & Trends Analysis Report by Cryoprotective Agents (Permeating Cryoprotectants and Non-Permeating Cryoprotectants), by Method (Slow Freezing, Vitrification, and Ultra-Rapid), by Application (Animal Husbandry, Fishery Science, Medical Science, Preservation of Microbiology Culture, and Conserving Plant Biodiversity), and by End-User (Life Science and Healthcare Facilities, and Research Laboratories) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/cryonics-technology-market
Increasing organ transplants is considered to be te another factor that is supporting the growth of the cryonics market across the globe. According to Health Resources & Services Administration (HRSA), around 40,000+ transplants were performed in 2021 in the US, and another 106, 162 patients are on the waiting list, which is increasing the growth of the cryonics market.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- Bio-Rad Laboratories Inc., GE HEALTHCARE, OREGON CRYONICS, Merck KGaA, and others.
Key questions addressed by the report
oRecovery Timeline
oDeviation from the pre-COVID forecast
oMost affected region/segment
Global Cryonics Technology Market– Segmentation
By Cryoprotective Agents
By Method
By Application
By end-user
Global Cryonics Technology Market by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cryonics-technology-market